Annovis Bio Inc (ANVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANVS | AMGN | VRTX | REGN | BMY |
| Company | Annovis Bio Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 10.59 | 333.00 | 499.70 | 1,082.64 | 49.06 |
| High | 10.65 | 338.57 | 506.15 | 1,092.46 | 49.31 |
| Low | 9.58 | 331.67 | 498.60 | 1,066.92 | 47.85 |
| Last | 9.80 | 334.28 | 502.15 | 1,074.48 | 48.98 |
| Change | -0.78 | +1.77 | +4.00 | -2.71 | +0.14 |
| % Change | -7.37% | +0.53% | +0.80% | -0.25% | +0.28% |
| Volume | 314,065 | 661,039 | 486,437 | 144,619 | 12,276,841 |
| 20-Day Average Volume | 4,983,631 | 1,745,038 | 935,258 | 371,107 | 16,893,096 |
| Previous Close | 10.58 | 332.51 | 498.15 | 1,077.19 | 48.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.51 | 326.83 | 488.55 | 1,066.57 | 42.85 |
| 20-Day Raw Stochastic | 39.29% | 65.78% | 88.29% | 62.67% | 81.88% |
| 20-Day Relative Strength | 50.24% | 63.05% | 68.33% | 56.64% | 68.78% |
| Weighted Alpha | -30.29 | +36.98 | +49.81 | +39.28 | -14.32 |
| Today's Opinion | 8% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 88% Buy | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.22% since 07/23/24 | -0.10% since 07/23/24 | +2.27% since 07/23/24 | +1.45% since 07/23/24 | +14.11% since 07/23/24 |
| Low | 9.58 on 07/30/24 | 330.34 on 07/24/24 | 486.25 on 07/24/24 | 1,052.81 on 07/24/24 | 43.25 on 07/24/24 |
| High | 11.69 on 07/24/24 | 346.85 on 07/25/24 | 506.15 on 07/30/24 | 1,102.95 on 07/25/24 | 51.19 on 07/29/24 |
| 1-Month | |||||
| %Chg | +69.70% since 06/28/24 | +6.55% since 06/28/24 | +6.98% since 06/28/24 | +1.89% since 06/28/24 | +18.10% since 06/28/24 |
| Low | 4.53 on 07/02/24 | 306.11 on 07/03/24 | 466.01 on 07/03/24 | 1,011.67 on 07/03/24 | 39.35 on 07/05/24 |
| High | 17.88 on 07/09/24 | 346.85 on 07/25/24 | 506.15 on 07/30/24 | 1,106.16 on 07/12/24 | 51.19 on 07/29/24 |
| 3-Month | |||||
| %Chg | +75.49% since 04/30/24 | +21.53% since 04/30/24 | +27.66% since 04/30/24 | +20.24% since 04/30/24 | +11.62% since 04/30/24 |
| Low | 4.53 on 07/02/24 | 273.38 on 05/01/24 | 392.47 on 05/01/24 | 888.52 on 05/01/24 | 39.35 on 07/05/24 |
| High | 17.88 on 07/09/24 | 346.85 on 07/25/24 | 506.15 on 07/30/24 | 1,106.16 on 07/12/24 | 51.19 on 07/29/24 |
| 6-Month | |||||
| %Chg | -9.07% since 01/30/24 | +5.81% since 01/30/24 | +12.41% since 01/30/24 | +11.58% since 01/30/24 | -0.70% since 01/30/24 |
| Low | 4.53 on 07/02/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.35 on 07/05/24 |
| High | 20.00 on 04/29/24 | 346.85 on 07/25/24 | 506.15 on 07/30/24 | 1,106.16 on 07/12/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 118,189 | 178,370,000 | 128,549,104 | 118,691,240 | 99,287,360 |
| Shares Outstanding, K | 11,171 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -56,200,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 12,201,000,000 |
| Last Quarter Net Income | -1,070,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,680,000,000 |
| 60-Month Beta | 1.75 | 0.58 | 0.39 | 0.13 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 05/13/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 08/20/24 | 08/06/24 | 08/01/24 | 08/01/24 | 07/26/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 07/05/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.97 | 32.89 | 29.07 | 36.82 |